Table of Contents
NATCHITOCHES, La. – Long recognized as a PBM leader in transparency and prescription drug savings, Liviniti announced the addition of the Mark Cuban Cost Plus Drug Company (Cost Plus Drugs) to its network of pharmacies. The consumer-focused approach of the two like-minded companies supports medication accessibility, price transparency and affordability for Liviniti members whose benefit plans choose to include Cost Plus Drugs as a pharmacy option.
Founded more than a dozen years ago as one of the nation’s pioneering PBM innovators, Liviniti launched a pass-through pricing approach that today drives the national conversation on PBM reform. Based on a fixed administrative fee instead of rebates, spread pricing or other opaque forms of revenue, the company’s business model continues to focus on new and better tools and technology to open up information to clients and patients.
“Our Cost Plus Drugs collaboration opens a new avenue to increased savings for members,” said LeAnn Boyd, Liviniti CEO. “With a longstanding commitment to a simple, transparent business model, the partnership between Liviniti and Cost Plus Drugs is a logical alliance. Providing this new pharmacy option to our clients and their members furthers our mission to transform pharmacy benefits through uncompromising integrity, leading innovation and real value for those we serve.”
